We are live on
!
Find out more
IC
Intersect Capital Portfolio holdings
AUM
$331M
1-Year Est. Return
6.79%
This Fund
S&P 500
This Quarter
Est. Return
+3.79%
1 Year Est. Return
-6.79%
3 Year Est. Return
+57.23%
5 Year Est. Return
+88.96%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$9.52M
(+5.7%)
Cap. Flow
+$3.75M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
41.72%
Holding
113
New
5
Increased
49
Reduced
33
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.44M |
| 2 |
iShares Preferred and Income Securities ETF
PFF
|
+$713K |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$573K |
| 4 |
First Trust Mid Cap Core AlphaDEX Fund
FNX
|
+$344K |
| 5 |
International Paper
IP
|
+$333K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$470K |
| 2 |
Meta Platforms (Facebook)
META
|
+$307K |
| 3 |
Costco
COST
|
+$231K |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$214K |
| 5 |
FedEx
FDX
|
+$200K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.24% |
| 2 | Technology | 10.77% |
| 3 | Communication Services | 9.67% |
| 4 | Healthcare | 8.72% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Amazon
AMZN
$2.76T
| $244K | 0.14% |
5,080
+760
| +18% | +$37.3K |
|
|
CELG
102
DELISTED
Celgene Corp
CELG
| $239K | 0.14% |
1,637
+89
| +6% | +$12.1K |
|
103
Vanguard Health Care ETF
VHT
$19.4B
| $236K | 0.13% |
1,550
| – | – |
|
104
GSK
GSK
$101B
| $233K | 0.13% |
4,584
| – | – |
|
105
iShares Select Dividend ETF
DVY
$23.8B
| $230K | 0.13% |
2,458
-190
| -7% | -$17.6K |
|
106
iShares Russell 1000 Value ETF
IWD
$84B
| $221K | 0.13% |
1,868
+1
| +0.1% | +$117 |
|
107
AB InBev
BUD
$156B
| $215K | 0.12% |
+1,804
| New | +$211K |
|
108
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $209K | 0.12% |
+3,365
| New | +$201K |
|
109
First Trust Dorsey Wright Focus 5 ETF
FV
$3.87B
| $205K | 0.12% |
+7,839
| New | +$199K |
|
|
SONN
110
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | – |
|
|
111
FedEx
FDX
$78.4B
| – | – |
-920
| Closed | -$200K |
|
112
Kinder Morgan
KMI
$70.2B
| – | – |
-10,242
| Closed | -$196K |
|
|
DD
113
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-2,650
| Closed | -$214K |
|
Similar funds
FPS
BWM
TF
CP
RIM
MWM
PPW
HA
Intersect Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Intersect Capital held 113 positions worth $176M, up 5.7% from $167M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Intersect Capital's Q3 2017 filing shows 5 new, 49 increased, 33 reduced and 3 closed positions. Its largest new stake was First Trust Mid Cap Core AlphaDEX Fund: 5,752 shares worth $356K. The largest sale was Altaba Inc, an estimated $470K.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 39% a quarter earlier, followed by Technology and Communication Services.
- Intersect Capital's largest Q3 2017 buy was First Trust Mid Cap Core AlphaDEX Fund: 5,752 shares worth $356K.
- Intersect Capital added most to iShares Russell 1000 Growth ETF in Q3 2017, an estimated $1.44M increase.
- Intersect Capital's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $470K.
- Intersect Capital fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $214K.
- Intersect Capital's ten largest holdings make up 42% of its $176M portfolio in Q3 2017.
- Intersect Capital opened 5 new positions and closed 3 in Q3 2017.
- Intersect Capital's portfolio value rose 5.7% quarter-over-quarter to $176M.
Based on Intersect Capital's 13F filing for Q3 2017, filed 13 Nov 2017.